Clinical Trial Update: Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Rina-S vs investigator's choice in platinum-resistant ovarian cancer; study status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Platinum-resistant Ovarian Cancer

Drugs mentioned

• Rina-S

Snippet

Sponsor: Genmab | Conditions: Platinum-resistant Ovarian Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING